-
Mashup Score: 1A meta-analysis study shows which patients with advanced prostate cancer live longer with chemotherapy | MRC Clinical Trials Unit at UCL - 3 year(s) ago
06 Jun 2022 A new study presented yesterday at the American Society of Clinical Oncology (ASCO) Meeting in Chicago recommends changes to practice after finding that docetaxel chemotherapy is substantially more effective for some patients with advanced prostate cancer than others. The…
Source: MRC Clinical Trials Unit at UCLCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Quality of life better in men taking abiraterone rather than docetaxel for hormone-sensitive prostate cancer | MRC Clinical Trials Unit at UCL - 4 year(s) ago
11 Nov 2021 Men being treated for prostate cancer with abiraterone have better quality of life than those treated with docetaxel. This is according to results from an analysis of quality of life data from the STAMPEDE trial, which was published yesterday in the Journal of Clinical…
Source: MRC Clinical Trials Unit at UCLCategories: Hem/Oncs, Latest HeadlinesTweet-
Quality of life better in men taking abiraterone rather than docetaxel for hormone-sensitive prostate cancer | MRC Clinical Trials Unit at UCL #pcsm https://t.co/eldX5zpG1i
-
RT @MRCCTU: (5/5) Read more about it here 👇 https://t.co/fupHIOLK8f